Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma.

Liu, Xiangjun; Jin, Shanzhao; Hu, Simeng; Li, Ruoyan; Pan, Haihao; Liu, Yi; Lai, Pan; Xu, Deshu et al. · Nat Commun · 2022

basic_science · Level V

Where this comes from

Abstract

Cutaneous T cell lymphoma (CTCL) represents a heterogeneous group of non-Hodgkin lymphoma distinguished by the presence of clonal malignant T cells. The heterogeneity of malignant T cells and the complex tumor microenvironment remain poorly characterized. With single-cell RNA analysis and bulk whole-exome sequencing on 19 skin lesions from 15 CTCL patients, we decipher the intra-tumor and inter-lesion diversity of CTCL patients and propose a multi-step tumor evolution model. We further establish a subtyping scheme based on the molecular features of malignant T cells and their pro-tumorigenic microenvironments: the T<sub>CyEM</sub> group, demonstrating a cytotoxic effector memory T cell phenotype, shows more M2 macrophages infiltration, while the T<sub>CM</sub> group, featured by a central memory T cell phenotype and adverse patient outcome, is infiltrated by highly exhausted CD8<sup>+</sup> reactive T cells, B cells and Tregs with suppressive activities. Our results establish a solid basis for understanding the nature of CTCL and pave the way for future precision medicine for CTCL patients.

Medical subject headings